National Lung Matrix Trial

Trial description
Multi-­drug, genetic marker-directed, non­-comparative, multi-­centre, multi­-arm phase II trial in non-small cell lung cancer
Contact name
Dr David Gilligan
Trial start date
Tuesday, November 17, 2015
Trial end date
Monday, December 31, 2018
Trial tumour type
Lung
Show on Radiotherapy
No